BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 23685279)

  • 21. Treatment of pulmonary neuroendocrine tumours: state of the art and future developments.
    Gridelli C; Rossi A; Airoma G; Bianco R; Costanzo R; Daniele B; Chiara GD; Grimaldi G; Irtelli L; Maione P; Morabito A; Piantedosi FV; Riccardi F
    Cancer Treat Rev; 2013 Aug; 39(5):466-72. PubMed ID: 22818212
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumour biology and histopathology of neuroendocrine tumours.
    Klöppel G
    Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):15-31. PubMed ID: 17382263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bronchopulmonary carcinoid tumors--a significant diagnostic problem.
    Kedra P; Jeleń M; Szkudlarek-Gruszczyńska T; Leśkow E
    Rocz Akad Med Bialymst; 1997; 42 Suppl 1():146-61. PubMed ID: 9337533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchopulmonary neuroendocrine tumors.
    Gustafsson BI; Kidd M; Chan A; Malfertheiner MV; Modlin IM
    Cancer; 2008 Jul; 113(1):5-21. PubMed ID: 18473355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neuroendocrine tumors of the lung].
    Takei H; Asamura H
    Nihon Rinsho; 2004 May; 62(5):877-82. PubMed ID: 15148812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosis and treatment of neuroendocrine lung tumors.
    Sánchez de Cos Escuín J
    Arch Bronconeumol; 2014 Sep; 50(9):392-6. PubMed ID: 24685201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with multiple synchronous carcinoid tumors.
    Montoro Zulueta FJ; Martínez Prieto M; Verdugo Cartas MI; Esteban Rodriguez I; Hernández Muñiz S
    Arch Bronconeumol; 2012 Dec; 48(12):472-5. PubMed ID: 22386668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What clinicians are asking pathologists when dealing with lung neuroendocrine neoplasms?
    Pelosi G; Fabbri A; Cossa M; Sonzogni A; Valeri B; Righi L; Papotti M
    Semin Diagn Pathol; 2015 Nov; 32(6):469-79. PubMed ID: 26561395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histopathology of neuroendocrine tumors].
    Saint-André JP; Dupré F; Chenue F; Guyétant S
    Ann Endocrinol (Paris); 1997; 58(2):101-11. PubMed ID: 9239228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants.
    Warren WH; Gould VE; Faber LP; Kittle CF; Memoli VA
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):819-25. PubMed ID: 2582209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative evaluation of three proliferation markers, Ki-67, TOP2A, and RacGAP1, in bronchopulmonary neuroendocrine neoplasms: Issues and prospects.
    Neubauer E; Wirtz RM; Kaemmerer D; Athelogou M; Schmidt L; Sänger J; Lupp A
    Oncotarget; 2016 Jul; 7(27):41959-41973. PubMed ID: 27259241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary Neuroendocrine Tumors.
    Borczuk AC
    Surg Pathol Clin; 2020 Mar; 13(1):35-55. PubMed ID: 32005434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytohistology of papillary carcinoid and emerging concept of pulmonary neuroendocrine neoplasms.
    Yang GC
    Diagn Cytopathol; 2016 Jan; 44(1):52-60. PubMed ID: 26457802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CGH findings in neuroendocrine tumours of the lung].
    Johnen G; Krismann M; Jaworska M; Müller KM
    Pathologe; 2003 Jul; 24(4):303-7. PubMed ID: 14513278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine tumors of the lung: clinicopathological and molecular features.
    Iyoda A; Azuma Y; Sano A
    Surg Today; 2020 Dec; 50(12):1578-1584. PubMed ID: 32193632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Symptoms and diagnostics of lung neuroendocrine tumors].
    Tamási L; Müller V
    Orv Hetil; 2011 Mar; 152(10):366-70. PubMed ID: 21354952
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical presentation and evaluation of neuroendocrine tumors of the lung.
    Detterbeck FC
    Thorac Surg Clin; 2014 Aug; 24(3):267-76. PubMed ID: 25065927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroendocrine tumors of the lung].
    Höfler H
    Verh Dtsch Ges Pathol; 1997; 81():118-24. PubMed ID: 9474862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management.
    Ferlito A; Devaney KO; Rinaldo A
    Oral Oncol; 2006 Sep; 42(8):770-88. PubMed ID: 16815077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.